VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CAI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CAICaris Life Sciences, Inc.
$25.23$7.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCAIQuarterly Financials

Caris Life Sciences, Inc. (CAI) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Caris Life Sciences, Inc. (CAI) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CAI Income Statement

Quarterly statement

CAI Income Statement

Caris Life Sciences, Inc. (CAI) annual income statement — 22-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20Q1'20Q4'19Q3'19
Sales/Revenue275.36M263.71M216.17M292.89M216.83M181.4M120.92M129.91M101.62M100.05M80.68M100.83M85.69M80.8M64.32M79.05M75.72M105.02M100.17M107.57M
Revenue Growth %26.99%45.38%78.78%125.44%113.38%81.31%49.88%----27.55%13.17%-23.06%-35.79%-26.51%-28.27%-5.48%-13.33%-6.83%
Cost of Goods Sold93.07M84.12M74.83M71.97M69.33M67.71M63.85M59.21M57.21M62.49M54.56M46.74M42.83M42.21M23.53M30.43M28.85M53.86M52.56M55.79M
COGS % of Revenue33.8%31.9%34.61%24.57%31.97%37.33%52.81%45.58%56.3%62.46%67.63%46.36%49.98%52.24%36.59%38.49%38.09%51.29%52.47%51.86%
Gross Profit182.28M179.6M141.35M220.91M147.51M113.69M57.06M70.7M44.41M37.55M26.11M54.09M42.87M38.59M40.79M48.62M46.88M51.16M47.61M51.78M
Gross Margin %66.2%68.1%65.39%75.43%68.03%62.67%47.19%54.42%43.7%37.54%32.37%53.64%50.02%47.76%63.41%61.51%61.91%48.71%47.53%48.14%
Gross Profit Growth %23.58%57.98%147.71%212.46%232.13%202.72%118.51%----11.24%-8.56%-24.57%-14.33%-6.1%-7.77%-6.65%-16.71%-8.57%
Operating Expenses162.97M152.67M136.07M132.5M114.86M95.7M115.02M107.75M105.25M-29.46M118.34M12.29M10.17M7.74M4.72M13.07M13.86M17.57M19.49M17.37M
OpEx % of Revenue59.18%57.89%62.94%45.24%52.97%52.75%95.12%82.94%103.58%-29.44%146.68%12.19%11.87%9.58%7.34%16.54%18.31%16.73%19.46%16.15%
Selling, General & Admin129.13M120.31M104.75M100.66M93.24M106.63M91.95M80.64M77.61M79.78M83.96M12.29M10.17M7.74M4.72M13.07M13.86M17.57M19.49M17.37M
SG&A % of Revenue46.9%45.62%48.46%34.37%43%58.78%76.04%62.07%76.37%79.74%104.07%12.19%11.87%9.58%7.34%16.54%18.31%16.73%19.46%16.15%
Research & Development33.84M32.36M5.37M31.84M21.62M25.05M23.07M27.11M27.64M24.79M34.38M000000000
R&D % of Revenue12.29%12.27%2.49%10.87%9.97%13.81%19.08%20.87%27.2%24.77%42.61%---------
Other Operating Expenses001000K00-1000K1K00-1000K0000000000
Operating Income19.32M26.93M5.28M88.41M32.64M17.99M-57.95M-37.05M-60.84M67.01M-92.22M66.44M50.84M48.76M36.06M35.55M33.02M33.59M28.12M34.41M
Operating Margin %7.01%10.21%2.44%30.19%15.05%9.92%-47.93%-28.52%-59.87%66.98%-114.31%65.9%59.33%60.35%56.07%44.97%43.6%31.98%28.07%31.99%
Operating Income Growth %-40.82%49.68%109.11%338.65%153.65%-73.16%37.16%----86.9%53.98%45.19%28.27%3.32%-4.1%-4.83%-27.54%-14.52%
EBITDA26.12M33.46M10.35M92.7M37.51M24.4M-50.91M-27.98M-50.34M78.62M-74.52M99.33M80.31M77.53M59.8M66.17M61.6M61.3M54.85M63.62M
EBITDA Margin %9.49%12.69%4.79%31.65%17.3%13.45%-42.1%-21.54%-49.54%78.58%-92.37%98.51%93.72%95.95%92.97%83.7%81.34%58.37%54.76%59.14%
EBITDA Growth %-30.36%37.16%120.33%431.32%174.51%-68.97%31.69%----50.11%30.38%26.47%9.02%4.01%2.38%-9.22%-22.87%-11.67%
D&A (Non-Cash Add-back)06.54M5.07M4.29M4.87M6.41M7.04M9.07M10.5M11.61M17.7M32.88M29.48M28.77M23.73M30.62M28.58M27.72M26.73M29.21M
EBIT26.12M8.61M12.16M93.31M37.83M-52.58M-89.8M-37.05M-60.84M-52.51M-101.74M050.91M48.35M57.54M34.94M34.66M15.79M27.31M36.44M
Net Interest Income-2.92M-2.41M-5.97M-4.34M-6.15M-17.59M-12.28M-12.29M-12.05M-11.03M-7.52M0-11.11M-11.17M-6.96M-16.63M-17.59M-20.38M-19.11M0
Interest Income6.33M6.82M6.83M7.01M7.36M1.62M503K970K1.74M2.64M1.77M000000000
Interest Expense9.25M9.23M12.81M11.36M13.51M19.21M12.78M13.26M13.8M13.67M9.29M011.11M11.17M6.96M16.63M17.59M20.38M19.11M20.12M
Other Income/Expense-2.44M-27.54M-5.93M-6.45M-8.32M-89.78M-44.63M99K-6.89M-133.2M-18.8M-11.61M-11.04M-11.58M-19.43M-18.76M-32.53M-38.17M-18.95M-18.09M
Pretax Income16.87M-614K-644K81.96M24.32M-71.79M-102.58M-36.95M-67.73M-66.19M-111.03M54.83M39.8M37.18M16.64M16.79M487K-4.59M9.17M16.32M
Pretax Margin %6.13%-0.23%-0.3%27.98%11.22%-39.58%-84.84%-28.44%-66.65%-66.15%-137.62%54.38%46.44%46.02%25.87%21.24%0.64%-4.37%9.15%15.17%
Income Tax1.62M23K-134K000000003.68M1.86M2.5M2.39M1.35M1.11M-3.26M1.32M1.15M
Effective Tax Rate %9.62%-3.75%20.81%0%0%0%0%0%0%0%0%6.71%4.66%6.73%14.39%8.03%228.54%71.02%14.41%7.06%
Net Income15.25M-637K-510K81.96M24.32M-71.79M-102.58M-36.95M-67.73M-66.19M-111.03M51.16M37.94M35.74M14.25M15.44M-626K-1.33M7.85M-4.75M
Net Margin %5.54%-0.24%-0.24%27.98%11.22%-39.58%-84.84%-28.44%-66.65%-66.15%-137.62%50.74%44.28%44.23%22.15%19.54%-0.83%-1.27%7.84%-4.41%
Net Income Growth %-37.31%99.11%99.5%321.82%135.92%-8.47%7.61%----231.25%6161.18%2787.22%81.5%425.32%-106.71%-107.16%-59.56%-121.82%
Net Income (Continuing)15.25M-637K-510K81.96M24.32M-71.79M-102.58M-36.95M-67.73M-66.19M-111.03M51.16M37.94M35.74M14.25M15.44M-626K-1.33M7.85M-4.75M
Discontinued Operations00000000000000000000
Minority Interest00000000--0000000000
EPS (Diluted)0.05-0.00-0.000.280.08-1.87-0.40-0.22-0.33-0.35-0.532.922.172.040.790.87-0.04-0.080.45-0.27
EPS Growth %-39.02%99.88%99.55%227.27%124.85%-434.29%24.53%----235.63%6195.51%2773.66%75.56%422.22%-106.85%-107.79%-55.45%-124.11%
EPS (Basic)0.05-0.00-0.000.290.09-1.93-0.40-0.22-0.33-0.35-0.532.952.202.070.800.88-0.04-0.080.45-0.27
Diluted Shares Outstanding295.14M282.89M282.56M289.89M297.21M276M254.79M281.09M281.09M254.79M254.79M17.53M17.48M17.52M17.95M17.71M17.6M17.43M17.43M17.52M
Basic Shares Outstanding283.89M282.89M282.56M282.33M282.1M268.44M254.79M281.09M281.09M254.79M254.79M17.34M17.28M17.27M17.71M17.57M17.47M17.43M17.43M17.33M
Dividend Payout Ratio-----------14.49%19.52%20.7%46.74%42.96%--28.13%-